Remove Burden Of Proof Remove Cross-Examination Remove Pharmaceuticals
article thumbnail

Federal Rule of Evidence 702: A Useful Rule (When It's Followed)

Evidence at Trial

Merrell Dow Pharmaceuticals, Inc. Another judge, likewise citing Daubert , might admit the opinion because "[v]igorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof are the traditional and appropriate means of attacking shaky but admissible evidence."